Scientists Reprogram Cancer Cells With Low Doses Of Epigenetic Drugs - News Story - Biocompare Buyer's Guide For Life Scientists

Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine  and decitabine , are epigenetic-targeted drugs and work to correct cancer-causing alterations that modify DNA.
Enhanced by Zemanta

No comments: